sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Typhoid Fever Vaccines Market...

Europe Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable) and Country

TIPRE00016086 | Pages: 90 | Pharmaceuticals | Nov 2020 | Type: Regional | Status: Published

Market Introduction

Typhoid is an infectious disease caused by Salmonella Typhi, through ingestion of contaminated food and water. This intense illness is identified by prolonged fever, headache and nausea, loss of appetite and constipation or sometimes diarrhea. Increasing threats of typhoid and growing threats of drug resistance has helped typhoid vaccines to boost its market especially among rural and hard-to-reach communities where progress in medical services, infrastructure and development may be slow.


Get more information on this report :



Market Overview and Dynamics

The Europe typhoid fever vaccines market is expected to reach US$ 145.36 million in 2027 from US$ 74.43 million in 2019. The market is estimated to grow with a CAGR of 9.0% from 2020-2027.  Factors such as increase in number of EU citizens travelling outside Europe and presence of market players in the European region is likely to contribute to the growth of the market. On the other hand, the market is likely to have negative impact due to risk of associated with typhoid fever vaccines.

Key Market Segments

On the basis of vaccine type, the typhoid fever vaccines market has been segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR in the market during the forecast period. Global typhoid fever vaccines market based on route of administration is segmented into oral and injectable. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR in the market during the forecast period

Major Sources and Companies Listed

Some of the major secondary sources for Europe typhoid fever vaccines market included in the report are, Spanish National Health System, International Trade Administration, World Health Organization and others.

Reasons to buy the report

  • To understand the Europe typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe typhoid fever vaccines market
  • Efficiently plan M&A and partnership deals in Europe typhoid fever vaccines market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe typhoid fever vaccines market
  • Obtain market revenue forecast for market by various segments from 2019-2027 in Europe.

 

Europe Typhoid Fever Vaccines Market –

By Vaccine Type

  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others

By Route of Administration

  • Oral
  • Injectable

By Country

  • Spain
  • Italy
  • UK
  • Germany
  • France

 

Company Profiles

  • Sanofi
  • GlaxoSmithKline plc
  • Paxvax Inc
  • Prokarium Ltd
  • Scandinavian Biopharma

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Typhoid Fever Vaccines Market – By Vaccine Type

1.3.2        Europe Typhoid Fever Vaccines Market – By Route of Administration

1.3.3        Europe Typhoid Fever Vaccines Market – By Country

2.          Europe Typhoid Fever Vaccines Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Europe Typhoid Fever Vaccines Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Europe Typhoid Fever Vaccines Market - Europe PEST Analysis

4.3        Expert Opinion

5.          Europe Typhoid Fever Vaccines Market Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Increase in Number of EU Citizens Travelling Outside Europe

5.1.2        Presence of Market Players in the European Region

5.2        Key Restraints

5.2.1        Side Effects Associated with Typhoid Fever Vaccines

5.3        Key Market Opportunities

5.3.1        Growing Pharmaceutical Industry

5.4        Future Trend

5.4.1        Strategic Developments by the Market Players

5.5        Impact Analysis

6.          Typhoid Fever Vaccines Market – Europe Analysis

6.1        Europe Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7.          Typhoid Fever Vaccines Market – By Vaccine Type

7.1        Overview

7.2        Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

7.3        Live Attenuated Vaccine

7.3.1        Overview

7.3.2        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Capsular Polysaccharide Vaccines

7.5.1        Overview

7.5.2        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Conjugate Vaccine

7.6.1        Overview

7.6.2        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7        Others

7.7.1        Overview

7.7.2        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.          Typhoid Fever Vaccines Market Analysis – By Route of Administration

8.1        Overview

8.2        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

8.2.1        Oral

8.2.1.1         Overview

8.2.2        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.3        Injectable

8.3.1        Overview

8.3.2        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.          Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1        Europe: Typhoid Fever Vaccines Market

9.1.1        Overview

9.1.2        Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.1.3        Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.4        Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.5        Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)

9.1.6        Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1         Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2         Germany: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.6.3         Germany: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.7        UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1         UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2         UK: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.7.3         UK: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.8        France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1         France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2         France: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.8.3         France: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.9        Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1         Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2         Spain: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.9.3         Spain: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.10     Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1       Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2       Italy: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.10.3       Italy: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

9.1.11     Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.1       Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.2       Rest of Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)

9.1.11.3       Rest of Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)

10.       Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

10.1     Europe: Impact Assessment of COVID-19 Pandemic

11.       Company Profiles

11.1     Paxvax Inc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2     Sanofi

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3     GlaxoSmithKline plc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4     Prokarium Ltd.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5     Scandinavian Biopharma

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

 


LIST OF TABLES

Table 1.            Europe Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 2.            Europe Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.            Germany Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 4.            Germany Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 5.            UK Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            UK Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.            France Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 8.            France Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 9.            Spain Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 10.         Spain Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.         Italy Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 12.         Italy Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 13.         Rest of Europe Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)

Table 14.         Rest of Europe Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 15.         Glossary of Terms, Europe Typhoid Fever Vaccines Market

 


LIST OF FIGURES

Figure 1.          Typhoid Fever Vaccines Market Segmentation

Figure 2.          Europe Typhoid Fever Vaccines Market Overview

Figure 3.          Capsular Polysaccharide Vaccines Segment Held Largest Share of Typhoid Fever Vaccines Market

Figure 4.          Germany Held the Largest Market Share During the Forecast Period

Figure 5.          Europe Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)

Figure 6.          Europe : PEST Analysis

Figure 7.          Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints

Figure 8.          Europe Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

Figure 10.        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 15.        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Europe: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 18.        Europe Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)

Figure 19.        Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)

Figure 20.        Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in European Countries

The List of Companies - Europe Typhoid Fever Vaccines Market

  1. Sanofi
  2. GlaxoSmithKline plc
  3. Paxvax Inc
  4. Prokarium Ltd
  5. Scandinavian Biopharma
  • To understand the Europe typhoid fever vaccines  market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe typhoid fever vaccines  market
  • Efficiently plan M&A and partnership deals in Europe typhoid fever vaccines  market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe typhoid fever vaccines  market
  • Obtain market revenue forecast for market by various segments from 2019-2027 in Europe.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription